<p><h1>Automated Antimicrobial Susceptibility Testing Market Analysis and Market Size: Global Industry Overview, Market Segmentation and Forecast (2024 to 2031)</h1></p><p><strong>Automated Antimicrobial Susceptibility Testing Market Analysis and Latest Trends</strong></p>
<p><p>Automated antimicrobial susceptibility testing (AST) is a method used in clinical microbiology to determine the effectiveness of antibiotics against microorganisms causing infections. It helps guide the selection of appropriate antimicrobial therapy for patients and aids in reducing the overall duration of diseases.</p><p>The market for automated antimicrobial susceptibility testing has been witnessing significant growth due to several factors. Firstly, the increasing prevalence of infectious diseases globally is leading to a higher demand for accurate and reliable testing methods to identify effective antibiotics quickly. Secondly, the rise in antimicrobial resistance worldwide necessitates the development and adoption of advanced technologies like automation in AST. Additionally, the growing awareness among healthcare professionals about the benefits of automated AST in improving patient outcomes and reducing healthcare costs is further driving the market growth.</p><p>In terms of market trends, the adoption of rapid AST systems is gaining traction. These systems enable faster and more accurate identification of antimicrobial susceptibility patterns, helping clinicians to make informed treatment decisions promptly. Moreover, the integration of advanced technologies like artificial intelligence and machine learning in automated AST systems is further enhancing their capabilities and efficiency.</p><p>The market is also witnessing collaborations and partnerships between diagnostic companies and pharmaceutical companies to develop and commercialize novel AST solutions. This trend aims to address the challenges posed by antimicrobial resistance and accelerate the development of effective antibiotics.</p><p>Overall, the automated antimicrobial susceptibility testing market is expected to experience substantial growth during the forecast period, driven by the need for rapid and accurate antibiotic susceptibility testing. According to market research, the market is projected to grow at a CAGR of 12.6% from the present till the completion of the forecast period.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/919695">https://www.reliableresearchreports.com/enquiry/request-sample/919695</a></p>
<p>&nbsp;</p>
<p><strong>Automated Antimicrobial Susceptibility Testing Major Market Players</strong></p>
<p><p>The automated antimicrobial susceptibility testing (AST) market is highly competitive, with several key players driving innovation and growth. Some of the prominent players in the market are bioMérieux, Thermo Fisher Scientific, Creative Diagnostics, HiMedia Laboratories, Becton, Dickinson and Company (BD), Alifax Holding, Bio-Rad Laboratories, Danaher Corporation, Resistell AG, and Merck KGaA.</p><p>bioMérieux is a leading player in the AST market, offering solutions such as VITEK 2 and ETEST for accurate and automated susceptibility testing. The company has a strong market presence and continues to invest in research and development. It has experienced consistent growth and is expected to grow further in the future. The exact market size and future growth projections for bioMérieux have not been disclosed.</p><p>Thermo Fisher Scientific, another key player in the market, provides automated AST solutions through its Sensititre system. The company has a wide range of products catering to the needs of clinical laboratories and research institutions. Thermo Fisher Scientific has witnessed significant market growth and is expected to continue expanding in the coming years. The company reported sales revenue of $30.6 billion in 2020.</p><p>BD, a global medical technology company, offers automated AST systems through its BD Phoenix platform. The company has a strong presence in the market and continues to innovate its products to meet the evolving needs of healthcare professionals. BD has reported sales revenue of approximately $17.2 billion in 2020, highlighting its significant market share and growth.</p><p>Danaher Corporation, a multinational conglomerate, operates in the AST market through its subsidiary Cepheid. The company's GeneXpert System is widely used for automated AST. Danaher Corporation has experienced substantial market growth and is expected to witness further expansion in the future. In 2020, Danaher Corporation reported sales revenue of $17.9 billion.</p><p>The overall market size of the automated AST market is estimated to be around $2.6 billion in 2020 and is projected to reach $4.6 billion by 2027, growing at a CAGR of 8.1% during the forecast period. Factors such as the increasing prevalence of antimicrobial resistance, the need for accurate and rapid testing methods, and advancements in technology are driving the market growth.</p><p>In conclusion, the automated AST market is highly competitive, with bioMérieux, Thermo Fisher Scientific, BD, and Danaher Corporation being key players driving growth. These companies have a strong market presence, invest in research and development, and have witnessed significant sales revenue. The overall market is expected to grow at a steady pace due to the increasing demand for accurate and rapid antimicrobial susceptibility testing.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Automated Antimicrobial Susceptibility Testing Manufacturers?</strong></p>
<p><p>The Automated Antimicrobial Susceptibility Testing (AST) market is witnessing significant growth due to the rising prevalence of infectious diseases and the need for accurate and rapid diagnosis. Additionally, the increasing adoption of automated systems in clinical laboratories to improve efficiency and reduce errors is driving market growth. Furthermore, the development of advanced technologies, such as machine learning and artificial intelligence, in AST is expected to further propel market expansion in the future. The emergence of resistant strains of bacteria and the growing focus on personalized medicine are also expected to contribute to the market's future growth.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/919695">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/919695</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Automated Antimicrobial Susceptibility Testing Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Consumables</li><li>Instruments</li></ul></p>
<p><p>Automated Antimicrobial Susceptibility Testing (AST) is divided into two market types: consumables and instruments. Consumables refer to the materials required for conducting the AST, such as reagents, culture media, and plates. These consumables need to be replenished regularly, making it a consistent revenue stream. On the other hand, instruments are the machines used to perform the AST, such as automated analyzer systems. The instruments market focuses on the sales of these machines, which are essential for conducting accurate and timely AST results.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/919695">https://www.reliableresearchreports.com/purchase/919695</a></p>
<p>&nbsp;</p>
<p><strong>The Automated Antimicrobial Susceptibility Testing Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Pharmaceutical and Biotechnology Companies</li><li>Contract Research Organizations</li><li>Hospitals</li><li>Pathology or Diagnostic Laboratories</li></ul></p>
<p><p>The market for Automated Antimicrobial Susceptibility Testing (AST) finds its application across various sectors such as pharmaceutical and biotechnology companies, contract research organizations, hospitals, and pathology or diagnostic laboratories. These companies and organizations utilize AST technology to determine the effectiveness of antibiotics and identify the most suitable treatment for various bacterial infections. AST helps in improving patient outcomes by providing accurate and fast test results, enabling healthcare professionals to make informed decisions regarding antibiotic therapy.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Automated Antimicrobial Susceptibility Testing Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The automated antimicrobial susceptibility testing (AST) market is poised to witness substantial growth in regions like North America (NA), Asia-Pacific (APAC), Europe, the USA, and China. North America is expected to dominate the market due to the presence of advanced healthcare infrastructure and a rising prevalence of drug-resistant infections. It is anticipated to hold a market share of around 35%. Europe and the USA are projected to account for approximately 25% each, owing to the increasing adoption of technologically advanced healthcare solutions. China and APAC are anticipated to exhibit impressive growth potential, contributing around 10% and 5% of the market share, respectively.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/919695">https://www.reliableresearchreports.com/purchase/919695</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/919695">https://www.reliableresearchreports.com/enquiry/request-sample/919695</a></p>
<p><strong></strong></p>
<p><p><a href="https://github.com/julyju69/Market-Research-Report-List-1/blob/main/ecg-tip-location-devices-market.md">ECG Tip Location Devices Market</a></p><p><a href="https://github.com/markusgodoy/Market-Research-Report-List-1/blob/main/lower-limb-arterial-stents-market.md">Lower Limb Arterial Stents Market</a></p><p><a href="https://medium.com/@samanthamason1930/die-cut-adhesives-nbsp-market-focuses-on-market-share-size-and-projected-forecast-till-2031-a474d227036f">Die Cut Adhesives Market</a></p><p><a href="https://medium.com/@samanthamason1930/analyzing-die-cut-materials-market-global-industry-perspective-and-forecast-2024-to-2031-00c5a4292551">Die Cut Materials Market</a></p><p><a href="https://medium.com/@shirleygreene26/composite-preform-market-analysis-and-sze-forecasted-for-period-from-2024-to-2031-9b42ca9b455c">Composite Preform Market</a></p></p>